These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8923801

  • 1. Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels.
    Pertz H.
    Planta Med; 1996 Oct; 62(5):387-92. PubMed ID: 8923801
    [Abstract] [Full Text] [Related]

  • 2. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH, Milhahn H, Eich E.
    J Med Chem; 1999 Feb 25; 42(4):659-68. PubMed ID: 10052973
    [Abstract] [Full Text] [Related]

  • 3. Simple O-acylated derivatives of lysergol and dihydrolysergol-I: synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha1 adrenergic receptors.
    Pertz HH, Brown AM, Gager TL, Kaumann AJ.
    J Pharm Pharmacol; 1999 Mar 25; 51(3):319-30. PubMed ID: 10344634
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
    Prins NH, Briejer MR, Schuurkes JA.
    Br J Pharmacol; 1997 Feb 25; 120(4):714-20. PubMed ID: 9051313
    [Abstract] [Full Text] [Related]

  • 5. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ, Cohen ML.
    J Pharmacol Exp Ther; 1993 Jan 25; 264(1):193-200. PubMed ID: 8423526
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle.
    Janssen P, Prins NH, Meulemans AL, Lefebvre RA.
    Br J Pharmacol; 2002 May 25; 136(2):321-9. PubMed ID: 12010782
    [Abstract] [Full Text] [Related]

  • 9. Precontraction with elevated concentrations of extracellular potassium enables both 5-HT1B and 5-HT2A "silent" receptors in rabbit ear artery.
    Smith JR, Kim C, Kim H, Purdy RE.
    J Pharmacol Exp Ther; 1999 Apr 25; 289(1):354-60. PubMed ID: 10087024
    [Abstract] [Full Text] [Related]

  • 10. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
    Killam AL, Nikam SS, Lambert GM, Martin AR, Nelson DL.
    J Pharmacol Exp Ther; 1990 Mar 25; 252(3):1083-9. PubMed ID: 2319460
    [Abstract] [Full Text] [Related]

  • 11. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W, Li MW, Thakali K, Fink GD, Watts SW.
    J Pharmacol Exp Ther; 2004 May 25; 309(2):845-52. PubMed ID: 14752059
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors.
    Schurad B, Horowski R, Jähnichen S, Görnemann T, Tack J, Pertz HH.
    Life Sci; 2006 Apr 11; 78(20):2358-64. PubMed ID: 16310806
    [Abstract] [Full Text] [Related]

  • 14. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML, Schenck KW, Kurz KD.
    J Cardiovasc Pharmacol; 1988 Apr 11; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [Abstract] [Full Text] [Related]

  • 15. Evidence for two populations of 5-hydroxytryptamine receptors in dog basilar artery.
    Frenken M.
    J Pharmacol Exp Ther; 1989 Jul 11; 250(1):379-87. PubMed ID: 2545865
    [Abstract] [Full Text] [Related]

  • 16. Enhanced G-protein coupled receptors-mediated contraction and reduced endothelium-dependent relaxation in hypertension.
    Li J, Cao YX, Liu H, Xu CB.
    Eur J Pharmacol; 2007 Feb 28; 557(2-3):186-94. PubMed ID: 17204265
    [Abstract] [Full Text] [Related]

  • 17. Receptor mechanisms for 5-hydroxytryptamine in isolated human umbilical artery and vein.
    Tuncer M, Doğan N, Oktay S, Kayaalp SO.
    Arch Int Pharmacodyn Ther; 1985 Jul 28; 276(1):17-27. PubMed ID: 2864904
    [Abstract] [Full Text] [Related]

  • 18. Rauwolscine induces contraction in the dog mesenteric artery precontracted with KCl and endothelin-1: mediation via 5-hydroxytryptamine1-like receptors.
    Shimamoto Y, Shimamoto H, Kwan CY, Daniel EE.
    J Pharmacol Exp Ther; 1993 Jan 28; 264(1):201-9. PubMed ID: 8093725
    [Abstract] [Full Text] [Related]

  • 19. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR, Joos GF, Pauwels RA.
    Br J Pharmacol; 1998 Apr 28; 123(8):1571-8. PubMed ID: 9605563
    [Abstract] [Full Text] [Related]

  • 20. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
    Verheggen R, Freudenthaler S, Meyer-Dulheuer F, Kaumann AJ.
    Br J Pharmacol; 1996 Jan 28; 117(2):283-92. PubMed ID: 8789380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.